CoChat
Sign Up
Cited by 136

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Ageing with HIV: Challenges and biomarkers

Rodés, Berta, Cadiñanos, Julen, Esteban-Cantos, Andrés, Rodríguez-Centeno, Javier, Arribas, José Ramón·2022·eBioMedicine
DOI 10.1016/j.ebiom.2022.103896PMC PMC8889090
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ebiom.2022.103896

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Interplay between HIV, ART and ageing. Hypothetical dynamics of the biological ageing process after HIV infection based on the studies performed in PLWH (red line) up to date. In untreated infection, the process seems more accelerated than non-HIV infection (blue line). With the introduction of ART, the biological ageing reverts. In this stage, the biological ageing is probably more accentuated than accelerated but the extent of this reversion remains unsettled.
Figure 1 Interplay between HIV, ART and ageing. Hypothetical dynamics of the biological ageing process after HIV infection based on the studies performed in PLWH (red line) up to date. In untreated infection, the process seems more accelerated than non-HIV infection (blue line). With the introduction of ART, the biological ageing reverts. In this stage, the biological ageing is probably more accentuated than accelerated but the extent of this reversion remains unsettled.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 91

  1. Fontela, 2020, Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population, Sci Rep, 10, 8922, 10.1038/s41598-020-65841-0 · DOI
  2. Marcus, 2020, Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000–2016, JAMA Netw Open, 3, 10.1001/jamanetworkopen.2020.7954 · DOI
  3. Autenrieth, 2018, Global and regional trends of people living with HIV aged 50 and over: estimates and projections for 2000–2020, PLoS One, 13, 10.1371/journal.pone.0207005 · DOI
  4. Smit, 2015, Future challenges for clinical care of an ageing population infected with HIV: a modelling study, Lancet Infect Dis, 15, 810, 10.1016/S1473-3099(15)00056-0 · DOI
  5. Schouten, 2014, Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study, Clin Infect Dis, 59, 1787, 10.1093/cid/ciu701 · DOI
  6. Verheij, 2021, Frequency, risk factors, and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV cohort participants, J Acquir Immune Defic Syndr, 86, 110, 10.1097/QAI.0000000000002532 · DOI
  7. Pathai, 2014, Is HIV a model of accelerated or accentuated aging?, J Gerontol A Biol Sci Med Sci, 69, 833, 10.1093/gerona/glt168 · DOI
  8. Ovadya, 2018, Impaired immune surveillance accelerates accumulation of senescent cells and aging, Nat Commun, 9, 5435, 10.1038/s41467-018-07825-3 · DOI · Paper page
  9. Mittelbrunn, 2021, Hallmarks of T cell aging, Nat Immunol, 22, 687, 10.1038/s41590-021-00927-z · DOI · Paper page
  10. Sokoya, 2017, HIV as a Cause of Immune Activation and Immunosenescence, Mediators Inflamm, 2017, 10.1155/2017/6825493 · DOI
  11. Appay, 2011, Old age and anti-cytomegalovirus immunity are associated with altered T-cell reconstitution in HIV-1-infected patients, AIDS, 25, 1813, 10.1097/QAD.0b013e32834640e6 · DOI
  12. Lu, 2021, The role of CD38 in HIV infection, AIDS Res Ther, 18, 11, 10.1186/s12981-021-00330-6 · DOI
  13. Sauce, 2021, Immune activation and chronic inflammation: is there an additional effect of HIV in a geriatric population?, Medicine (Baltimore), 100, e25678, 10.1097/MD.0000000000025678 · DOI
  14. Moir, 2014, B-cell exhaustion in HIV infection: the role of immune activation, Curr Opin HIV AIDS, 9, 472, 10.1097/COH.0000000000000092 · DOI
  15. Prabhu, 2019, Monocyte based correlates of immune activation and viremia in HIV-infected long-term non-progressors, Front Immunol, 10, 2849, 10.3389/fimmu.2019.02849 · DOI
  16. Frasca, 2021, Metabolic phenotype of B cells from young and elderly HIV individuals, Immun Ageing, 18, 35, 10.1186/s12979-021-00245-w · DOI
  17. Kohli, 2021, The struggle of a good friend getting old: cellular senescence in viral responses and therapy, EMBO Rep, 22, e52243, 10.15252/embr.202052243 · DOI · Paper page
  18. Angelovich, 2015, Viremic and virologically suppressed HIV infection increases age-related changes to monocyte activation equivalent to 12 and 4 years of aging, respectively, J Acquir Immune Defic Syndr, 69, 11, 10.1097/QAI.0000000000000559 · DOI
  19. Bellon, 2017, Telomere dynamics in immune senescence and exhaustion triggered by chronic viral infection, Viruses, 9, 289, 10.3390/v9100289 · DOI
  20. Tassiopoulos, 2012, CD28-negative CD4+ and CD8+ T cells in antiretroviral therapy-naive HIV-infected adults enrolled in adult clinical trials group studies, J Infect Dis, 205, 1730, 10.1093/infdis/jis260 · DOI
  21. Breton, 2013, Programmed death-1 is a marker for abnormal distribution of naive/memory T cell subsets in HIV-1 infection, J Immunol, 191, 2194, 10.4049/jimmunol.1200646 · DOI
  22. Lagathu, 2017, Basic science and pathogenesis of ageing with HIV: potential mechanisms and biomarkers, AIDS, 31, S105, 10.1097/QAD.0000000000001441 · DOI
  23. Miura, 2003, Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy, J Med Virol, 70, 497, 10.1002/jmv.10423 · DOI
  24. Gross, 2016, Methylome-wide analysis of Chronic HIV infection reveals five-year increase in biological age and epigenetic targeting of HLA, Mol Cell, 62, 157, 10.1016/j.molcel.2016.03.019 · DOI
  25. Nikolich-Žugich, 2020, Advances in cytomegalovirus (CMV) biology and its relationship to health, diseases, and aging, Geroscience, 42, 495, 10.1007/s11357-020-00170-8 · DOI
  26. Wada, 2015, The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation, AIDS, 29, 463, 10.1097/QAD.0000000000000545 · DOI
  27. Lundgren, 2015, Initiation of antiretroviral therapy in early asymptomatic HIV infection, N Engl J Med, 373, 795, 10.1056/NEJMoa1506816 · DOI
  28. Cobos Jiménez, 2016, T-cell activation independently associates with immune senescence in HIV-infected recipients of long-term antiretroviral treatment, J Infect Dis, 214, 216, 10.1093/infdis/jiw146 · DOI
  29. Grund, 2016, Relevance of interleukin-6 and D-dimer for serious non-AIDS morbidity and death among HIV-positive adults on suppressive antiretroviral therapy, PLoS One, 11, 10.1371/journal.pone.0155100 · DOI
  30. Cohen, 2018, HIV antiretroviral therapy drugs induce premature senescence and altered physiology in HUVECs, Mech Ageing Dev, 175, 74, 10.1016/j.mad.2018.07.008 · DOI
  31. Gelpi, 2019, Prior exposure to thymidine analogs and didanosine is associated with long-lasting alterations in adipose tissue distribution and cardiovascular risk factors, AIDS, 33, 675, 10.1097/QAD.0000000000002119 · DOI
  32. Schank, 2021, The impact of HIV- and ART-induced mitochondrial dysfunction in cellular senescence and aging, Cells, 10, 174, 10.3390/cells10010174 · DOI
  33. Birkus, 2002, Assessment of mitochondrial toxicity in human cells treated with tenofovir: comparison with other nucleoside reverse transcriptase inhibitors, Antimicrob Agents Chemother, 46, 716, 10.1128/AAC.46.3.716-723.2002 · DOI
  34. Chen, 2019, Endothelial mitochondrial senescence accelerates cardiovascular disease in antiretroviral-receiving HIV patients, Toxicol Lett, 317, 13, 10.1016/j.toxlet.2019.09.018 · DOI
  35. Warriner, 2014, Bone alterations associated with HIV, Curr HIV/AIDS Rep, 11, 233, 10.1007/s11904-014-0216-x · DOI
  36. Heron, 2020, Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV, AIDS Res Ther, 17, 11, 10.1186/s12981-020-00266-3 · DOI
  37. Dorjee, 2017, Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study, BMC Infect Dis, 17, 708, 10.1186/s12879-017-2808-8 · DOI
  38. Sax, 2020, Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials, Clin Infect Dis, 71, 1379, 10.1093/cid/ciz999 · DOI
  39. Kheloufi, 2017, Neuropsychiatric events and dolutegravir in HIV patients: a worldwide issue involving a class effect, AIDS, 31, 1775, 10.1097/QAD.0000000000001557 · DOI
  40. van Welzen, 2021, Dual antiretroviral therapy-all quiet beneath the surface?, Front Immunol, 12, 10.3389/fimmu.2021.637910 · DOI
  41. Hamczyk, 2020, Biological versus chronological aging: JACC focus seminar, J Am Coll Cardiol, 75, 919, 10.1016/j.jacc.2019.11.062 · DOI
  42. Sabin, 2017, Epidemiology of ageing with HIV: what can we learn from cohorts?, AIDS, 31, S121, 10.1097/QAD.0000000000001374 · DOI
  43. Milic, 2019, European cohorts of older HIV adults: POPPY, AGEhIV, GEPPO, COBRA and FUNCFRAIL, Eur Geriatr Med, 10, 247, 10.1007/s41999-019-00170-8 · DOI
  44. Tate, 2019, Veterans Aging Cohort Study (VACS) and the Antiretroviral Therapy Cohort Collaboration (ART-CC). Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals, AIDS, 33, 903, 10.1097/QAD.0000000000002140 · DOI
  45. Al Saedi, 2019, Current and emerging biomarkers of frailty in the elderly, Clin Interv Aging, 14, 389, 10.2147/CIA.S168687 · DOI
  46. 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin Pharmacol Ther, 69, 89, 10.1067/mcp.2001.113989 · DOI
  47. Guerville, 2020, Revisiting the hallmarks of aging to identify markers of biological age, J Prev Alzheimers Dis, 7, 56, 10.14283/jpad.2019.50 · DOI
  48. Rivero-Segura, 2020, Promising biomarkers of human aging: in search of a multi-omics panel to understand the aging process from a multidimensional perspective, Ageing Res Rev, 64, 10.1016/j.arr.2020.101164 · DOI
  49. Lin, 2010, Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance, J Immunol Methods, 352, 71, 10.1016/j.jim.2009.09.012 · DOI · Paper page
  50. Liu, 2015, Absolute leukocyte telomere length in HIV-infected and uninfected individuals: evidence of accelerated cell senescence in HIV-associated chronic obstructive pulmonary disease, PLoS One, 10
  51. Alejos, 2019, Determinants of blood telomere length in antiretroviral treatment-naïve HIV-positive participants enrolled in the NEAT 001/ANRS 143 clinical trial, HIV Med, 20, 691, 10.1111/hiv.12791 · DOI
  52. Gonzalez-Serna, 2017, Rapid decrease in peripheral blood mononucleated cell telomere length after HIV seroconversion, but not HCV seroconversion, J Acquir Immune Defic Syndr, 76, e29, 10.1097/QAI.0000000000001446 · DOI
  53. Leung, 2017, Longitudinal study of surrogate aging measures during human immunodeficiency virus seroconversion, Aging (Albany NY), 9, 687, 10.18632/aging.101184 · DOI
  54. Stella-Ascariz, 2018, Blood telomere length changes after ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1, J Infect Dis, 218, 1523, 10.1093/infdis/jiy399 · DOI
  55. Raffenberg, 2021, Impact of delaying antiretroviral treatment during primary HIV infection on telomere length, J Infect Dis, 10, 1775
  56. Montejano, 2018, Impact of Nucleos(t)ide reverse transcriptase inhibitors on blood telomere length changes in a prospective cohort of aviremic HIV-infected adults, J Infect Dis, 218, 1531, 10.1093/infdis/jiy364 · DOI
  57. Mehta, 2021, Telomere length is associated with HIV infection, methamphetamine use, inflammation, and comorbid disease risk, Drug Alcohol Depend, 221, 10.1016/j.drugalcdep.2021.108639 · DOI
  58. Engel, 2021, Telomere length, traditional risk factors, HIV-related factors and coronary artery disease events in swiss persons living with HIV, Clin Infect Dis, 73, e2070, 10.1093/cid/ciaa1034 · DOI
  59. Russell, 2020, Rate of dyslipidemia higher among women living with HIV: a comparison of metabolic and cardiovascular health in a cohort to study aging in HIV, HIV Med, 21, 418, 10.1111/hiv.12843 · DOI
  60. Sánchez-Conde, 2019, Frailty phenotype: a clinical marker of age acceleration in the older HIV-infected population, Epigenomics, 11, 501, 10.2217/epi-2018-0130 · DOI
  61. De Francesco, 2019, Do people living with HIV experience greater age advancement than their HIV-negative counterparts?, AIDS, 33, 259, 10.1097/QAD.0000000000002063 · DOI
  62. Levine, 2018, An epigenetic biomarker of aging for lifespan and healthspan, Aging (Albany NY), 10, 573, 10.18632/aging.101414 · DOI · Paper page
  63. Marioni, 2015, DNA methylation age of blood predicts all-cause mortality in later life, Genome Biol, 16, 25, 10.1186/s13059-015-0584-6 · DOI · Paper page
  64. Rickabaugh, 2015, Acceleration of age-associated methylation patterns in HIV-1-infected adults, PLoS One, 10, 10.1371/journal.pone.0119201 · DOI
  65. Nelson, 2017, Identification of HIV infection-related DNA methylation sites and advanced epigenetic aging in HIV-positive, treatment-naive U.S. veterans, AIDS, 31, 571, 10.1097/QAD.0000000000001360 · DOI
  66. Yang, 2021, Occurrence of accelerated epigenetic aging and methylation disruptions in human immunodeficiency virus infection before antiretroviral therapy, J Infect Dis, 223, 1681, 10.1093/infdis/jiaa599 · DOI
  67. Esteban-Cantos, 2021, Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial, Lancet HIV, 8, e197, 10.1016/S2352-3018(21)00006-0 · DOI
  68. Horvath, 2015, HIV-1 infection accelerates age according to the epigenetic clock, J Infect Dis, 212, 1563, 10.1093/infdis/jiv277 · DOI · Paper page
  69. Sehl, 2020, The effects of anti-retroviral therapy on epigenetic age acceleration observed in HIV-1-infected adults, Pathog Immun, 5, 291, 10.20411/pai.v5i1.376 · DOI
  70. Esteban-Cantos, 2021, Longitudinal changes in epigenetic age acceleration in aviremic HIV-infected recipients of long-term antiretroviral treatment, J Infect Dis, jiab338
  71. Sundermann, 2019, Inflammation-related genes are associated with epigenetic aging in HIV, J Neurovirol, 25, 853, 10.1007/s13365-019-00777-4 · DOI
  72. Shu, 2021, DNA methylation biomarker selected by an ensemble machine learning approach predicts mortality risk in an HIV-positive veteran population, Epigenetics, 16, 741, 10.1080/15592294.2020.1824097 · DOI
  73. Li, 2020, Longitudinal trajectories, correlations and mortality associations of nine biological ages across 20-years follow-up, eLife, 9, e51507, 10.7554/eLife.51507 · DOI · Paper page
  74. Shiau, 2021, Epigenetic aging biomarkers associated with cognitive impairment in older African American adults with HIV, Clin Infect Dis, 73, 1982, 10.1093/cid/ciab563 · DOI
  75. Zhang, 2018, Machine learning selected smoking-associated DNA methylation signatures that predict HIV prognosis and mortality, Clin Epigenetics, 10, 155, 10.1186/s13148-018-0591-z · DOI
  76. Pinto, 2015, Mechanisms linking mtDNA damage and aging, Free Radic Biol Med, 85, 250, 10.1016/j.freeradbiomed.2015.05.005 · DOI
  77. Hunt, 2020, Mitochondria and ageing with HIV, Curr Opin HIV AIDS, 15, 101, 10.1097/COH.0000000000000607 · DOI
  78. Hsieh, 2020, Inverse relationship between leukocyte telomere length attrition and blood mitochondrial DNA content loss over time, Aging (Albany NY), 12, 15196, 10.18632/aging.103703 · DOI
  79. Bürkle, 2015, MARK-AGE biomarkers of ageing, Mech Ageing Dev, 151, 2, 10.1016/j.mad.2015.03.006 · DOI
  80. Cassol, 2013, Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors, BMC Infect Dis, 13, 203, 10.1186/1471-2334-13-203 · DOI
  81. Yeoh, 2017, Immunometabolic and lipidomic markers associated with the frailty index and quality of life in aging HIV+ men on antiretroviral therapy, EBioMedicine, 22, 112, 10.1016/j.ebiom.2017.07.015 · DOI
  82. Babu, 2019, Plasma metabolic signature and abnormalities in HIV-infected individuals on long-term successful antiretroviral therapy, Metabolites, 9, E210, 10.3390/metabo9100210 · DOI
  83. Babu, 2019, Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy, Front Immunol, 10, 1965, 10.3389/fimmu.2019.01965 · DOI
  84. De Francesco, 2020, Monocyte and T cell immune phenotypic profiles associated with age advancement differ between people with HIV, lifestyle-comparable controls and blood donors, Front Immunol, 11, 10.3389/fimmu.2020.581616 · DOI
  85. Hove-Skovsgaard, 2020, Impact of age and HIV status on immune activation, senescence and apoptosis, Front Immunol, 11, 10.3389/fimmu.2020.583569 · DOI
  86. Bunet, 2021, Loss of CD96 expression as a marker of HIV-specific CD8+ T-cell differentiation and dysfunction, Front Immunol, 12, 10.3389/fimmu.2021.673061 · DOI
  87. Falutz, 2020, Frailty in people living with HIV, Curr HIV/AIDS Rep, 17, 226, 10.1007/s11904-020-00494-2 · DOI
  88. Sundermann, 2019, Inflammation-related genes are associated with epigenetic aging in HIV, J Neurovirol, 25, 853, 10.1007/s13365-019-00777-4 · DOI
  89. de Armas, 2021, Immunological age prediction in HIV-infected, ART-treated individuals, Aging (Albany NY), 13, 22772, 10.18632/aging.203625 · DOI
  90. Cole, 2017, Increased brain-predicted aging in treated HIV disease, Neurology, 88, 1349, 10.1212/WNL.0000000000003790 · DOI
  91. Cole, 2018, No evidence for accelerated aging-related brain pathology in treated human immunodeficiency virus: longitudinal neuroimaging results from the comorbidity in relation to AIDS (COBRA) project, Clin Infect Dis, 66, 1899, 10.1093/cid/cix1124 · DOI

Cited by

Sorted by citations

Metadata

Authors
Rodés, B., Cadiñanos, J., Esteban-Cantos, A., Rodríguez-Centeno, J., & Arribas, J. R.
Venue
eBioMedicine
Publisher
Elsevier BV
Published
2022-03
Volume
77
Pages
103896
ISSN
2352-3964
DOI
10.1016/j.ebiom.2022.103896
PMC
PMC8889090
Cited by
136
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review